AtriCure was formed by a team with extensive experience in the medical device industry. The company is focused on developing innovative products using proprietary technology that provides doctors alternative, expedient methods to ablate tissue during surgical procedures.
WEST CHESTER, Ohio, Sep 08, 2010 (BUSINESS WIRE) --AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems and systems for the exclusion of the
left atrial appendage, today announced that it will participate in the
following investor conferences during September:
The UBS Global Life Sciences Conference at the Grand Hyatt New York.
Management is scheduled to present at 3:00 p.m. Eastern Ti...
Highlights
Revenue of $14.2 million - strengthening U.S. revenues of $11.8 million
Positive cash from operations during the quarter of $1.1 million
Loss from operations improves 58 percent - record low of $0.4 million
Obtained commitment to expand borrowing capacity under existing credit
facility
Obtained FDA clearance and initiated launch of the AtriClipTM
...
WEST CHESTER, Ohio, Jul 15, 2010 (BUSINESS WIRE) --AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the following investor conferences during August:
The BMO Capital Markets 10th Annual Focus on Healthcare
Conference at the Sheraton New York Hotel and Towers. Management is
scheduled to present at 11:15 a.m. on Thursday, August 5, 2010....
WEST CHESTER, Ohio, Jul 14, 2010 (BUSINESS WIRE) --AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the second quarter ended June 30, 2010 on Wednesday, August 4, 2010.
AtriCure will host a conference call at 10:00 a.m. Eastern Time on
Wednesday, August 4, 2010 to discuss its second quarter 2010 financial
results. A live web cast of the conference call will be av...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
